Blockbuster Oncology Brands Market (2024 - 2030) Size, Share & Trends Analysis Report By Brands (Opdivo, Keytruda, Perjeta, Ibrance), By Treatment (Lung Cancer, Lymphoma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                        1.3.1. Information Procurement
                        1.3.2. Information or Data Analysis
                        1.3.3. Market Formulation & Data Visualization
                        1.3.4. Data Validation & Publishing
                    1.4. Research Scope and Assumptions
                        1.4.1. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Blockbuster Oncology Brands Market Variables, Trends, & Scope
                    3.1. Market Introduction/Lineage Outlook
                    3.2. Market Size and Growth Prospects (USD Billion)
                    3.3. Market Dynamics
                        3.3.1. Market Drivers Analysis
                        3.3.2. Market Restraints Analysis
                    3.4. Blockbuster Oncology Brands Market Analysis Tools
                        3.4.1. Porter’s Analysis
                            3.4.1.1. Bargaining power of the suppliers
                            3.4.1.2. Bargaining power of the buyers
                            3.4.1.3. Threats of substitution
                            3.4.1.4. Threats from new entrants
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political Landscape
                            3.4.2.2. Economic and Social Landscape
                            3.4.2.3. Technological Landscape
                            3.4.2.4. Environmental Landscape
                            3.4.2.5. Legal Landscape
Chapter 4. Blockbuster Oncology Brands Market: Brands Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Blockbuster Oncology Brands Market: Brands Movement Analysis, 2023 & 2030 (USD Billion)
                    4.3. Opdivo
                        4.3.1. Opdivo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.4. Keytruda
                        4.4.1. Keytruda Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.5. Perjeta
                        4.5.1. Perjeta Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.6. Ibrance
                        4.6.1. Ibrance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.7. Tecentriq
                        4.7.1. Tecentriq Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.8. Gazyva
                        4.8.1. Gazyva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.9. Tagrisso
                        4.9.1. Tagrisso Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.10. Darzalex
                        4.10.1. Darzalex Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.11. Zejula
                        4.11.1. Zejula Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.12. Revlimid
                        4.12.1. Revlimid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.13. Imbruvica
                        4.13.1. Imbruvica Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.14. Others
                        4.14.1. Other Brands Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Blockbuster Oncology Brands Market: Treatment Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Blockbuster Oncology Brands Market: Treatment Movement Analysis, 2023 & 2030 (USD Billion)
                    5.3. Lung Cancer
                        5.3.1. Lung Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.4. Breast Cancer
                        5.4.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.5. Multiple Myeloma
                        5.5.1. Multiple Myeloma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.6. Lymphoma
                        5.6.1. Lymphoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.7. Others
                        5.7.1. Other Treatments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Blockbuster Oncology Brands Market: Distribution Channel Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Blockbuster Oncology Brands Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Billion)
                    6.3. Hospital Pharmacy
                        6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.4. Retail Pharmacy
                        6.4.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.5. Other
                        6.5.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Blockbuster Oncology Brands Market: Regional Estimates & Trend Analysis
                    7.1. Blockbuster Oncology Brands Market Share, By Region, 2023 & 2030 (USD Billion)
                    7.2. North America
                        7.2.1. North America Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.2.2. U.S.
                            7.2.2.1. U.S. Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.2.3. Canada
                            7.2.3.1. Canada Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.2.4. Mexico
                            7.2.4.1. Mexico Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.3. Europe
                        7.3.1. Europe Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.2. U.K.
                            7.3.2.1. U.K. Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.3. Germany
                            7.3.3.1. Germany Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.4. France
                            7.3.4.1. France Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.5. Italy
                            7.3.5.1. Italy Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.6. Spain
                            7.3.6.1. Spain Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.7. Denmark
                            7.3.7.1. Denmark Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.8. Sweden
                            7.3.8.1. Sweden Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.3.9. Norway
                            7.3.9.1. Norway Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.4. Asia Pacific
                        7.4.1. Asia Pacific Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.4.2. China
                            7.4.2.1. China Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.4.3. Japan
                            7.4.3.1. Japan Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.4.4. India
                            7.4.4.1. India Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.4.5. South Korea
                            7.4.5.1. South Korea Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.4.6. Australia
                            7.4.6.1. Australia Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.4.7. Thailand
                            7.4.7.1. Thailand Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.5. Latin America
                        7.5.1. Latin America Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.5.2. Brazil
                            7.5.2.1. Brazil Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.5.3. Argentina
                            7.5.3.1. Argentina Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.6. Middle East and Africa
                        7.6.1. Middle East and Africa Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.6.2. Saudi Arabia
                            7.6.2.1. Saudi Arabia Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.6.3. South Africa
                            7.6.3.1. South Africa Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.6.4. UAE
                            7.6.4.1. UAE Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        7.6.5. Kuwait
                            7.6.5.1. Kuwait Blockbuster Oncology Brands Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis by Key Market Participants
                    8.2. Company Categorization
                    8.3. Company Heat Map Analysis
                    8.4. Company Profiles
                        8.4.1. Bristol-Myers Squibb Company
                            8.4.1.1. Participant’s Overview
                            8.4.1.2. Financial Performance
                            8.4.1.3. Product Benchmarking
                            8.4.1.4. Recent Developments/ Strategic Initiatives
                        8.4.2. Merck & Co., Inc.
                            8.4.2.1. Participant’s Overview
                            8.4.2.2. Financial Performance
                            8.4.2.3. Product Benchmarking
                            8.4.2.4. Recent Developments/ Strategic Initiatives
                        8.4.3. Pfizer Inc.
                            8.4.3.1. Participant’s Overview
                            8.4.3.2. Financial Performance
                            8.4.3.3. Product Benchmarking
                            8.4.3.4. Recent Developments/ Strategic Initiatives
                        8.4.4. F. Hoffmann-La Roche Ltd
                            8.4.4.1. Participant’s Overview
                            8.4.4.2. Financial Performance
                            8.4.4.3. Product Benchmarking
                            8.4.4.4. Recent Developments/ Strategic Initiatives
                        8.4.5. AstraZeneca
                            8.4.5.1. Participant’s Overview
                            8.4.5.2. Financial Performance
                            8.4.5.3. Product Benchmarking
                            8.4.5.4. Recent Developments/ Strategic Initiatives
                        8.4.6. GSK plc
                            8.4.6.1. Participant’s Overview
                            8.4.6.2. Financial Performance
                            8.4.6.3. Product Benchmarking
                            8.4.6.4. Recent Developments/ Strategic Initiatives
                        8.4.7. Novartis AG
                            8.4.7.1. Participant’s Overview
                            8.4.7.2. Financial Performance
                            8.4.7.3. Product Benchmarking
                            8.4.7.4. Recent Developments/ Strategic Initiatives
                        8.4.8. Johnson & Johnson Services, Inc.
                            8.4.8.1. Participant’s Overview
                            8.4.8.2. Financial Performance
                            8.4.8.3. Product Benchmarking
                            8.4.8.4. Recent Developments/ Strategic Initiatives
                        8.4.9. AbbVie Inc.
                            8.4.9.1. Participant’s Overview
                            8.4.9.2. Financial Performance
                            8.4.9.3. Product Benchmarking
                            8.4.9.4. Recent Developments/ Strategic Initiatives
                        8.4.10. Amgen Inc.
                            8.4.10.1. Participant’s Overview
                            8.4.10.2. Financial Performance
                            8.4.10.3. Product Benchmarking
                            8.4.10.4. Recent Developments/ Strategic Initiatives